These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8225689)

  • 21. Comparison of the nicotine pharmacokinetics of Nicoderm (nicotine transdermal system) and half-hourly cigarette smoking.
    Gupta SK; Hwang SS; Causey D; Rolf CN; Gorsline J
    J Clin Pharmacol; 1995 Oct; 35(10):985-9. PubMed ID: 8568016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tolerability and pharmacokinetics of single and repeated doses of nicotine with The Straw, a novel nicotine replacement product.
    D'Orlando KJ; Fox BS
    Nicotine Tob Res; 2004 Feb; 6(1):63-70. PubMed ID: 14982689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Case studies of three pregnant smokers and their use of nicotine replacement therapy.
    Hotham ED; Gilbert AL; Atkinson ER
    Midwifery; 2005 Sep; 21(3):224-32. PubMed ID: 15967546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single- and multiple-dose pharmacokinetics of Nicoderm (Nicotine Transdermal System).
    Gupta SK; Okerholm RA; Coen P; Prather RD; Gorsline J
    J Clin Pharmacol; 1993 Feb; 33(2):169-74. PubMed ID: 8440767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Steady-state pharmacokinetics and dose relationship of nicotine delivered from Nicoderm (Nicotine Transdermal System).
    Gorsline J; Gupta SK; Dye D; Rolf CN
    J Clin Pharmacol; 1993 Feb; 33(2):161-8. PubMed ID: 8440766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of transdermal nicotine delivery on measures of acute nicotine withdrawal.
    Pickworth WB; Fant RV; Butschky MF; Henningfield JE
    J Pharmacol Exp Ther; 1996 Nov; 279(2):450-6. PubMed ID: 8930145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transdermal delivery of nicotine in normal human volunteers: a single dose and multiple dose study.
    Bannon YB; Corish J; Corrigan OI; Devane JG; Kavanagh M; Mulligan S
    Eur J Clin Pharmacol; 1989; 37(3):285-90. PubMed ID: 2612544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Population pharmacokinetic model of transdermal nicotine delivered from a matrix-type patch.
    Linakis MW; Rower JE; Roberts JK; Miller EI; Wilkins DG; Sherwin CMT
    Br J Clin Pharmacol; 2017 Dec; 83(12):2709-2717. PubMed ID: 28771779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rate of nicotine onset from nicotine replacement therapy and acute responses in smokers.
    Perkins KA; Lerman C; Keenan J; Fonte C; Coddington S
    Nicotine Tob Res; 2004 Jun; 6(3):501-7. PubMed ID: 15203784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usefulness of markers in managing tobacco withdrawal.
    Roussel G; Roche D; Momas I; Brahimi N; Callais F; Lequang NT; Labrousse F
    Pathol Biol (Paris); 1997 Jun; 45(6):467-71. PubMed ID: 9309261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nicotine patches and the subjective effects of cigarette smoking: a pilot study.
    Cárdenas L; Busto UE; MacDonald A; Corrigall WA
    Can J Clin Pharmacol; 2002; 9(4):175-82. PubMed ID: 12584575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of over-the-counter sales of the nicotine patch and nicotine gum on smoking cessation in California.
    Reed MB; Anderson CM; Vaughn JW; Burns DM
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2131-6. PubMed ID: 16172221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Smoking cessation: a clinical study of the transdermal nicotine patch.
    Smith TM; Winters FD
    J Am Osteopath Assoc; 1995 Nov; 95(11):655-6, 661-2. PubMed ID: 8575948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and in vitro/in vivo evaluations of bioadhesive buccal tablets for nicotine replacement therapy.
    Ikinci G; Senel S; Tokgözoğlu L; Wilson CG; Sumnu M
    Pharmazie; 2006 Mar; 61(3):203-7. PubMed ID: 16599260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Steady-state nicotine plasma levels following use of four different types of Swedish snus compared with 2-mg Nicorette chewing gum: a crossover study.
    Lunell E; Lunell M
    Nicotine Tob Res; 2005 Jun; 7(3):397-403. PubMed ID: 16085507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determinants of plasma concentrations of nicotine and cotinine during cigarette smoking and transdermal nicotine treatment.
    Gourlay SG; Benowitz NL; Forbes A; McNeil JJ
    Eur J Clin Pharmacol; 1997; 51(5):407-14. PubMed ID: 9049583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics and bioavailability of nicotine in healthy volunteers following single and repeated administration of different doses of transdermal nicotine systems.
    Dubois JP; Sioufi A; Müller P; Mauli D; Imhof PR
    Methods Find Exp Clin Pharmacol; 1989 Mar; 11(3):187-95. PubMed ID: 2725117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the pharmacokinetics of two nicotine transdermal systems: nicoderm and habitrol.
    Gupta SK; Okerholm RA; Eller M; Wei G; Rolf CN; Gorsline J
    J Clin Pharmacol; 1995 May; 35(5):493-8. PubMed ID: 7657849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An oral formulation of nicotine for release and absorption in the colon: its development and pharmacokinetics.
    Green JT; Evans BK; Rhodes J; Thomas GA; Ranshaw C; Feyerabend C; Russell MA
    Br J Clin Pharmacol; 1999 Oct; 48(4):485-93. PubMed ID: 10583017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of multiple daily transdermal doses of nicotine in healthy smokers.
    Ross HD; Chan KK; Piraino AJ; John VA
    Pharm Res; 1991 Mar; 8(3):385-8. PubMed ID: 2052530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.